Hyman R. Kahn
Directeur/Membre du Conseil chez MacroArray Technologies LLC
Profil
Hyman R.
Kahn is currently a Director at eMindful, Inc., Thomas Jefferson University Hospital, MacroArray Technologies LLC, and Ben Franklin Technology Partners.
He previously served as a Director at InstaMed Holdings, Inc., Immune Control, Inc., and Quaker Partners Management LP.
He was also a Senior Vice President at US Healthcare, Inc. and a Member at LORE Associates, Inc.
Postes actifs de Hyman R. Kahn
| Sociétés | Poste | Début |
|---|---|---|
Ben Franklin Technology Partners /Ventures/
 Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Consultant / Advisor | 07/08/2009 |
| Thomas Jefferson University Hospital | Directeur/Membre du Conseil | - |
MacroArray Technologies LLC
 MacroArray Technologies LLC BiotechnologyHealth Technology MacroArray Technologies LLC operates as a biotechnology research firm. It offers proteomics platform for novel marker discovery; DNA-protein binding technology, methods for cloning/identification of genes/proteins; immunoassays for tissue/fluid markers; linking diagnostic markers and DNA ZYM therapeutic agents for the treatment of cancer. The company was founded by Youji Yu, Youji Hu, Min Wang, Michael J. Wassil and Mark E. Stearns and is headquartered in Villanova, PA. | Directeur/Membre du Conseil | - |
eMindful, Inc.
 eMindful, Inc. Miscellaneous Commercial ServicesCommercial Services eMindful, Inc. provides evidence-based behavioral change programs online. It offers online courses in the areas of stress reduction, weight loss and management, diabetes, pain management, mental health, cancer, heart disease, and relapse. The company offers its services through licensed health professionals, includes physicians and psychotherapists to employers, healthcare providers, and individuals, as well as insurers, third-party administrators, and brokers. The company was founded by Kelley McCabe in 2007 and is headquartered in Vero Beach, FL. | Directeur/Membre du Conseil | 06/09/2011 |
Anciens postes connus de Hyman R. Kahn
| Sociétés | Poste | Fin |
|---|---|---|
Immune Control, Inc.
 Immune Control, Inc. Pharmaceuticals: MajorHealth Technology Immune Control is an emerging pharmaceutical company developing novel, orally available, small molecules for autoimmune/inflammatory diseases. The company is commercializing the discovery that serotonin is a required growth factor for dividing lymphocytes. Certain serotonin antagonists eliminate activated or dividing T- or B-lymphocytes without disturbing resting lymphocytes. The ability to kill activated immune cells selectively has important implications for treating autoimmune/inflammatory diseases, hematologic cancers, and organ transplant rejection. Immune Control is a first-mover and the leader in the emerging field of serotonin-based immunotherapeutics. Their preclinical development program has yielded important insights into the design of orally available, potent, small molecules for autoimmune/inflammatory conditions. Immune Control is focused initially on two diseases: rheumatoid arthritis and asthma. Immune Control designs and develops novel compounds using in vitro and in vivo assays for receptor binding, efficacy, safety, and bioavailability. In 2008, the company plans to nominate two compounds as IND candidates for RA and asthma. In addition, they are conducting phase 1, proof-of-concept clinical trials in multiple myeloma and psoriasis, utilizing a currently approved serotonin antagonist. | Directeur/Membre du Conseil | 06/12/2012 |
Quaker Partners Management LP
 Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management LP (Quaker Partners Mgmt) is a venture capital subsidiary of Independence Capital Partners Inc founded in 2002 by Ira Mark Lubert and Paul Sherrill Neff. The firm is headquartered in Philadelphia, Pennsylvania. | Private Equity Investor | 30/03/2010 |
InstaMed Holdings, Inc.
 InstaMed Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services InstaMed Holdings, Inc. operates a cloud-based healthcare payments network focused on healthcare providers, payers, and patients. The company was founded by Christopher D. Seib and William F. Marvin in 2004 and is headquartered in Philadelphia, PA. | Directeur/Membre du Conseil | - |
LORE Associates, Inc.
 LORE Associates, Inc. Investment ManagersFinance LORE Associates Inc. (LORE Associates) is a venture capital firm founded in 1988. The firm is headquartered in Philadelphia, Pennsylvania. | Private Equity Investor | - |
US Healthcare, Inc.
 US Healthcare, Inc. Medical/Nursing ServicesHealth Services Part of CVS Health Corp., US Healthcare, Inc. is a company that provides healthcare services for individuals, families, and businesses. US Healthcare, Inc. is based in Blue Bell, PA. US Healthcare was acquired by Aetna, Inc., part of CVS Health Corp. from November 29, 2018 on July 19, 1996 for $8,114.05 million. The company was founded by Benad Goldwasser, Angelo Masciantonio. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
US Healthcare, Inc.
US Healthcare, Inc. Medical/Nursing ServicesHealth Services Part of CVS Health Corp., US Healthcare, Inc. is a company that provides healthcare services for individuals, families, and businesses. US Healthcare, Inc. is based in Blue Bell, PA. US Healthcare was acquired by Aetna, Inc., part of CVS Health Corp. from November 29, 2018 on July 19, 1996 for $8,114.05 million. The company was founded by Benad Goldwasser, Angelo Masciantonio. | Health Services |
InstaMed Holdings, Inc.
InstaMed Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services InstaMed Holdings, Inc. operates a cloud-based healthcare payments network focused on healthcare providers, payers, and patients. The company was founded by Christopher D. Seib and William F. Marvin in 2004 and is headquartered in Philadelphia, PA. | Commercial Services |
eMindful, Inc.
eMindful, Inc. Miscellaneous Commercial ServicesCommercial Services eMindful, Inc. provides evidence-based behavioral change programs online. It offers online courses in the areas of stress reduction, weight loss and management, diabetes, pain management, mental health, cancer, heart disease, and relapse. The company offers its services through licensed health professionals, includes physicians and psychotherapists to employers, healthcare providers, and individuals, as well as insurers, third-party administrators, and brokers. The company was founded by Kelley McCabe in 2007 and is headquartered in Vero Beach, FL. | Commercial Services |
Quaker Partners Management LP
Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management LP (Quaker Partners Mgmt) is a venture capital subsidiary of Independence Capital Partners Inc founded in 2002 by Ira Mark Lubert and Paul Sherrill Neff. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
Immune Control, Inc.
Immune Control, Inc. Pharmaceuticals: MajorHealth Technology Immune Control is an emerging pharmaceutical company developing novel, orally available, small molecules for autoimmune/inflammatory diseases. The company is commercializing the discovery that serotonin is a required growth factor for dividing lymphocytes. Certain serotonin antagonists eliminate activated or dividing T- or B-lymphocytes without disturbing resting lymphocytes. The ability to kill activated immune cells selectively has important implications for treating autoimmune/inflammatory diseases, hematologic cancers, and organ transplant rejection. Immune Control is a first-mover and the leader in the emerging field of serotonin-based immunotherapeutics. Their preclinical development program has yielded important insights into the design of orally available, potent, small molecules for autoimmune/inflammatory conditions. Immune Control is focused initially on two diseases: rheumatoid arthritis and asthma. Immune Control designs and develops novel compounds using in vitro and in vivo assays for receptor binding, efficacy, safety, and bioavailability. In 2008, the company plans to nominate two compounds as IND candidates for RA and asthma. In addition, they are conducting phase 1, proof-of-concept clinical trials in multiple myeloma and psoriasis, utilizing a currently approved serotonin antagonist. | Health Technology |
Ben Franklin Technology Partners /Ventures/
Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
LORE Associates, Inc.
LORE Associates, Inc. Investment ManagersFinance LORE Associates Inc. (LORE Associates) is a venture capital firm founded in 1988. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
MacroArray Technologies LLC
MacroArray Technologies LLC BiotechnologyHealth Technology MacroArray Technologies LLC operates as a biotechnology research firm. It offers proteomics platform for novel marker discovery; DNA-protein binding technology, methods for cloning/identification of genes/proteins; immunoassays for tissue/fluid markers; linking diagnostic markers and DNA ZYM therapeutic agents for the treatment of cancer. The company was founded by Youji Yu, Youji Hu, Min Wang, Michael J. Wassil and Mark E. Stearns and is headquartered in Villanova, PA. | Health Technology |
